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Summary: Thirty patients suffering from chronic kidney disease were examined for urinary, fecal and total plasma
porphyrins. Twenty patients had nitrogen retention whereas the remaining ten patients displayed normal values.
Urinary coproporphyrin excretion and total plasma porphyrin levels were comparatively less pronounced in patients
with nitrogen retention. Such changes in porphyrin metabolism could be explained by a diminished capacity for
kidney excretion. It is concluded that the total amount of porphyrins synthesized in the body is decreased as a
result of nitrogen retention.
Gesamt-Plasmaporphyrine bei Nierenkrankheiten
Zusammenfassung: Die Harn-, Kot- und Plasmaporphyrine wurden bei 30 chronisch Nierenkranken (10 ohne und
20 mit Stickstoffretention) untersucht. Bei Kranken mit Stickstoffretention waren die Koproporphyrinausscheidung im
Harn und die gesamten Plasmaporphyrine stärker erniedrigt. Diese Veränderungen im Porphyrinstoffwechsel sind eine
Folge der beschränkten Ausscheidungskapazität der Nieren. Außerdem ist eine Verminderung der gesamten im Orga-
nismus synthetisierten Porphyrinmenge infolge der Stickstoffretention anzunehmen.
Although the kidneys play an important part in the
elimination of porphyrins, studies on the mechanism of
urinary porphyrin excretion (1—3) and the changes in
porphyrin metabolism in renal disease (1,4) are sur-
prisingly few. The liver is also involved in the excretion
of porphyrins, 2/3 to 4/5 of the total amount of por-
phyrins being excreted through the bile (5,6). In
abnormal conditions hepatic and renal porphyrin ratios
of excretion undergo conspicuous changes. In obstruc-
tive jaundice fecal coproporphyrin is reduced whereas
urinary coproporphyrin increases (6), but high plasma
porphyrin levels were found in only a few patients with
cholestasis (in preparation). A rise of plasma porphyrin
has been demonstrated on experimental models in rab-
bits suffering from mechanical anuria with a concpmi^
tant obstructive jaundice. In either of these situations,




Thirty patients with renal diseases (10 without and 20 with
nitrogen retention) were included in the study. Twenty one
patients had chronic pyelonephritis. In three of them the
disorder was associated with diabetes mellitus. Five patients had
chronic nephritis, three -= chronic glomerulonephritis and 1 —
endemic nephropathy. The diagnosis and the stage of the disease
were determined by means of numerous clinical, laboratory,
biochemical, hematological and functional tests.
Methods
Plasma porphyrins were assayed by the procedure ofSchlenker
et al. (7), urinary uroporphyrin by that of Gutniak & Dancewicz
(8) and coproporphyrin by the Rimington technique (9). Stools:
uroporphyrin was detected by a technique described by Ivanov
(10), coproporphyrin and protoporphyrin — after Rimington 's
technique (9). Blood urea and hemoglobin data determined the
stage of the disease. The results were statistically processed at a
significance level of p ^  0.05.
Results
A list of all patients with the diagnosis and the results of
laboratory procedures is shown on Table 1 and the sta-
stistical processing — on Table 2.
Excretion of urinary coproporphyrin was substantially
reduced in patients with renal disease, the decrease
being more pronounced in patients with nitrogen reten-
tion. Urinary uroporphyrin was also low, being lower in
patients with compensated renal disease. Fecal uro-,
copro- and protoporphyrin excretion was normal in both
groups of patients with renal disease. Plasma porphyrin
levels were reduced, but there was no significant differ-
ence between patients with and without nitrogen reten-
J. Clin. Chem. Clin. Biochem. / Vol. 14,1976 / No. 5
214 Ivanov and Drenska: Total plasma porphyrins in renal disease
































































































































































































































































































































































































































C = compensated D = decompensated
Tab. 2. Statistical processing of the results of studies of the parameters of porphyrin metabolism in compensated and decompensated
renal disease.
Group
































































The results are expressed by χ ± SD.
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tion. The type of changes depended upon the stage of
the renal disease — whether it was compensated or not —
and not on the specific disease itself.
Discussion
In accordance with our earlier studies in patients with
endemic nephropathy, chronic nephritis and pyelone-
phritis (4), a low urinary coproporphyrin excretion was
found. Since coproporphyrin is excreted in the urine on
the basis of threshold-free substances its excretion dimi-
nishes as early as the stage of compensation parallel to
the initial impairment of renal function. Nitrogen reten-
tion leads to a further decrease in coproporphyrin excre-
tion. All these phenomena suggest that these findings
are due to a diminished excretory capacity of the kid-
neys. One may expect that plasma porphyrin is elevated
during the stage of the decompensation of renal disease,
although it contains more protoporphyrin than copropor-
phyrin. Another possibility may be an increase in porphy-
rin excretion with the stools if the liver compensatorily
undertakes the excretion of porphyrins normally excre-
ted through the urine. Fecal porphyrins, however, were
not increased in patients with renal disease. Plasma por-
phyrin values were reduced as well.
This laboratory constellation characterizing porphyrin
metabolism in renal disease may result from the decrease
in the total amount of synthesized porphyrins or possibly
from a process of decreased degradation. Considering the
frequent development of pronounced anemia in decom-
pensated renal disease („nephrogenic anemia") it may be
assumed that the porphyrins synthesized in the bone
marrow are in fact the reduced ones. Further studies on
this problem are mandatory for the elucidation on the
role of the disorders of porphyrin biosynthesis in the
pathogenesis of porphyrin metabolism changes in renal
disease.
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